Abstract 2060P
Background
The aim of the study is to identify the prevalence and predictors of mental adjustment to cancer in patients who were going to resect lung for non-small cell lung cancer in Korea.
Methods
A total of 697 patients were recruited from September 2021 to October 2022 and completed a survey questionnaire of the Korean version of Mini-Mental Adjustment to Cancer (K-Mini-MAC) which higher mean score denote worse mental adjustment, except for positive attitude (PA) domain. Multivariable logistic regression was analyzed to determine potential predictors of poor adjustment to cancer for each domain of K-mini-MAC, which was defined by the mean score of 2.5 or higher, while PA domain was defined by mean score of 2.5 or lower.
Results
The mean age of study population was 63.2 ± 0.4 years old and 50.4% was male. The proportion of poor mental adjustment was 6.0% (Helpless/Hopeless [HH] domain), 29.6% (Anxious Preoccupation [AP] domain), 19.1% (PA domain), and 30.1% (Cognitive Avoidance [CA] domain). The mean score of each domain was 1.60 ± 0.02 (HH), 2.17 ± 0.02 (AP), 2.83 ± 0.02 (PA), and 2.62 ± 0.02 (CA). Younger age (<65 years old, aOR 1.78, 95% CI 1.15-2.76) and having comorbidity (aOR 1.64, 95% CI 1.09-2.45) were associated with poor mental adjustment in AP domain, while current alcohol drinking was associated with better mental adjustment in AP domain (aOR 0.56, 95% CI 0.32-0.96, vs. non-alcohol drinker). Poor mental adjustment in PA domain was predicted based on Lower education level (≤ middle school, aOR 1.97, 95% CI 1.12-3.46; high school, aOR 2.31, 95% CI 1.23-4.36, vs. ≥ university). There was no significant predictor for mental adjustment in HH and CA domain.
Conclusions
Younger, non-alcohol drinker, having comorbidity and lower educational level was associated with a poor adjustment to cancer. Interventions to help with adjustment to cancer should be focused particularly on these group.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
This research was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (Grant Number: MSIT; 2019R1A2C2009751).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06